On August 2, 2022, R&G Pharmastudies Co., Ltd. (SHE: 301333), a China-leading CRO enterprise invested by Legend Capital, was successfully…
Search Results: Tot Biopharm (105)
Group to use proceeds for future viable investment and purchase of equipment Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155),…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and…
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG 3681), a Hong Kong-listed biopharmaceutical company…
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies…
Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing world-famous greater health products, announced today its audited…
Focuses on Specialty Esoteric Testing Business Optimizes Vertical and Horizontal Industry Chain Deployment Kindstar Globalgene Technology, Inc. (Kindstar Globalgene or…
Malaysian Genomics Resource Centre Berhad (“MGRC” or “the Group”), a leading genomics and biopharmaceutical specialist, today announced that it recorded…
2021 the 11th Hong Kong International Finance Forum & China Securities Golden Bauhinia Awards Ceremony, themed “The 14th Five-Year, a…
Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent)…
Adlai Nortye Ltd. (hereinafter referred to as Adlai Nortye), a global biopharmaceutical company focused on developing innovative oncology drugs, today…
The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical…
China Medical System Holdings Limited (HKG:867) (CMS or the Company) has been active in the market this year. From the…
Cielo, the world’s leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to…
The Group’s Revenue Surged by 115.7% YoY Revenue from the CFS Business Increased Significantly by 146.3% YoY…
Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD…
Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment Novamind Inc. (CSE:NM) (“Novamind”), a…
Hua Medicine (HKG:2552), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today…
Promote R&D and Marketing of Drug Candidates & Form Production and Commercialization Platform SinoMab BioScience Limited (“SinoMab” or the “Company”,…
Antengene Corporation Limited (“Antengene” or the “Company”, together with its subsidiaries, the “Group”, stock code: 6996.HK), a clinical-stage biopharmaceutical company…